Overview
- Congress promulgated Law No. 32658 on Wednesday, June 17, 2026, and the measure was published in the official gazette El Peruano with the president’s signature.
- The statute makes updating the national Clinical Practice Guideline for multiple sclerosis a matter of national interest and requires the guideline be refreshed every three years.
- The Ministry of Health must submit an annual report on progress closing gaps in services and treatments to the Congressional Health and Population Commission and to patient associations, and must coordinate awareness activities on May 30 with regional and local governments.
- Patient advocates who led the push say the law will raise visibility and help defend patients’ rights, but they and health experts say the key test will be how the government implements guideline revisions, reporting procedures and measures to expand timely diagnosis and treatment access.
- Multiple sclerosis is an immune‑mediated disease that mainly affects young adults and women; Peru has no consolidated national registry and patient groups estimate 2,000–3,000 people in the country, so the law could reshape policy and services if its reporting and guideline requirements are enforced.